Sitagliptin

Sitagliptin is a DPP‑4 inhibitor with modest HbA1c reduction and cardiovascular neutrality; it has no demonstrated heart failure outcome benefit. DPP-4 inhibitors may in fact exacerbate heart failure symptoms through oedema worsening. This is not the best drug for Mr. Green.

Please go back and re-consider. 

  • Assign a coordinator but without explaining roles [undo]
  • Isosorbide mononitrate [undo]
  • Explore symptoms that may indicate medication-related liver injury [undo]
  • Ενίσχυση DNA [undo]
  • Propylthiouracil [undo]
  • The History of alcohol use [undo]
  • Decreased entry of glucose into muscle cells [undo]
  • Που θα οδηγήσει [undo]
  • Medios de cultivo [undo]
  • Propylthiouracil, propranolol [undo]
  • *vatsan kurinaa* [undo]
  • History of Allergies [undo]
  • Propylthiouracil, propranolol, hydrocortisone [undo]
  • Node 2: Discuss Maria's feelings and concerns [undo]
  • Guanethidine [undo]
  • Commercial Platform [undo]
  • Balanzas de laboratorio I [undo]
  • Ignore the emotional expression. [undo]
  • DNA template, RNA polymerase, dNTPs, Buffer solution [undo]
  • Ramipril (ACE inhibitor) [undo]
  • Las células HeLa son naturalmente resistentes a todos los fármacos [undo]
  • Opțiunea 3: Pentru a afla despre echipamentul individual de protecție (EIP) și conduita în laborator [undo]
  • Respond bluntly: “That is common in diabetes.” [undo]
  • Insulin [undo]
  • B, C, F [undo]
  • Decreased production of glucose from the liver [undo]
  • Sitagliptin [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21101
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway